
PCR Market for Life Sciences and Diagnostics (qPCR & dPCR, TMA and Other NAAT)
Description
PCR Testing Market for Life Sciences and Diagnostics (qPCR, dPCR and other NAAT)
Polymerase chain reaction (PCR) technology is used in life science (research) activities and also in clinical medicine. PCR Testing Market for Life Sciences and Diagnostics (qPCR, dPCR and other NAAT) includes opportunity estimates for both research and diagnostic uses of PCR, by geography, with forecasts to 2021; global analysis of PCR and other NAAT technologies; examination of the applications of PCR and other NAAT in research and clinical diagnostics; tables listing agreements made by PCR and other NAAT companies, including investments and financing agreements, acquisitions, collaborations, and other agreements; and examination of market forces, issues, and trends in the nucleic acid amplification market. Abbott Laboratories, Agilent Technologies, Hologic, Qiagen, Roche, and Thermo Fisher Scientific are among the companies active in PCR and other NAAT products and applications that are profiled in the report.
Polymerase chain reaction (PCR) technology is used in life science (research) activities and also in clinical medicine. PCR Testing Market for Life Sciences and Diagnostics (qPCR, dPCR and other NAAT) includes opportunity estimates for both research and diagnostic uses of PCR, by geography, with forecasts to 2021; global analysis of PCR and other NAAT technologies; examination of the applications of PCR and other NAAT in research and clinical diagnostics; tables listing agreements made by PCR and other NAAT companies, including investments and financing agreements, acquisitions, collaborations, and other agreements; and examination of market forces, issues, and trends in the nucleic acid amplification market. Abbott Laboratories, Agilent Technologies, Hologic, Qiagen, Roche, and Thermo Fisher Scientific are among the companies active in PCR and other NAAT products and applications that are profiled in the report.
Table of Contents
427 Pages
- Nucleic Acid Amplification Testing Overview
- Scope and Methodology
- Market Overview
- Future Prospects in the PCR Market
- Development and Evolution of Polymerase Chain Reaction and Other Nucleic Acid Amplification Tests
- Point-of-View
- Polymerase Chain Reaction (PCR) - Overview
- Other Nucleic Acid Amplification Test (NAAT) Methods
- Platforms Used in Different NAAT Markets - Research, Clinical Laboratories, and Point-of-Care Testing
- New Applications of PCR - Combining PCR with Other Technologies
- Research Applications of Polymerase Chain Reaction
- Infectious Disease Diagnostics
- Oncology
- Cardiovascular Disease
- Genetic Testing
- Other Clinical Applications of Polymerase Chain Reaction
- Transfusion Medicine - Blood Screening
- Non-Clinical Applications of Polymerase Chain Reaction
- Investments and Financing Agreements
- Mergers and Acquisitions
- Corporate Agreements and Collaborations (Not Including Pharmaceutical Companies)
- Collaborations/Agreements with Pharmaceutical and Biopharmaceutical Companies
- Collaborations and Other Agreements with Universities, Non-Profit Research Institutes and Government
- Issues and Hurdles Faced by PCR Companies Selling to the Life Science (Research) Market
- Clinical Market Drivers
- Point-of-Care Testing Market Drivers and Challenges/Hurdles
- Competition from Companies Utilizing PCR and Other NAAT Technologies
- Competition and Market Opportunities Driven by Other (non-NAAT) Technologies
- Regulation of In Vitro Diagnostics
- Laboratory Developed Tests
- Reimbursement
- Future Prospects
- Nucleic Acid Amplification Test Market Overview
- Life Science NAAT Market
- Clinical NAAT Market - Global Market
- Clinical (Diagnostic) NAAT Market - Infectious Disease
- Clinical (Diagnostic) NAAT Market - Oncology
- Clinical (Diagnostic) NAAT Market - Genetic Testing
- Clinical (Diagnostic) NAAT Market - Transplantation Diagnostics
- NAAT Blood Screening Market
- Abbott Laboratories
- Agena Bioscience, Inc.
- Agilent Technologies Inc.
- Alere Inc.
- Amoy Diagnostics Co., Ltd.
- Asuragen, Inc.
- Atlas Genetics Ltd
- AutoGenomics, Inc.
- Beckman Coulter, Inc. (A Danaher Corporation Company)
- Becton, Dickinson and Company (BD)
- Biocartis Group NV
- BioFire Diagnostics, LLC. (Acquired by bioMérieux)
- bioMérieux SA
- Bio-Rad Laboratories, Inc.
- Bruker Corporation
- Canon BioMedical
- Cepheid (A Danaher Company)
- Curetis
- DiaSorin S.p.A.
- Eiken Chemical Co., Ltd.
- ELITechGroup
- GenePOC Inc.
- GenMark Diagnostics, Inc.
- Genomic Health, Inc.
- Grifols
- Hologic, Inc.
- Invivoscribe Technologies, Inc.
- Janssen Diagnostics (Division of Janssen Pharmaceutica NV)
- Luminex Corporation
- Mast Group
- Meridian Bioscience, Inc.
- Multiplicom NV (Part of Agilent Technologies)
- QIAGEN N.V.
- QuanDx Inc.
- QuantuMDx Group
- Quidel, Inc.
- Qvella Corporation
- RainDance Technologies, Inc. (Acquired by Bio-Rad Laboratories)
- Roche
- Siemens Healthineers
- Spartan Bioscience Inc.
- STAT-Diagnostica
- T2 Biosystems, Inc.
- Thermo Fisher Scientific, Inc.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.